Neurotensin (CAS 39379-15-2): Precision Tool for GPCR Trafficking and miRNA Regulation

Executive Summary: Neurotensin is a 13-amino acid neuropeptide that binds Neurotensin receptor 1 (NTR1), a G protein-coupled receptor (GPCR) highly expressed in the central nervous system and gastrointestinal tissues. Upon NTR1 activation, neurotensin triggers intracellular cascades that modulate microRNA expression, notably upregulating miR-133α, which targets aftiphilin (AFTPH) to regulate receptor recycling. The product from APExBIO (SKU B5226) is characterized by ≥98% purity, a molecular weight of 1672.94 Da, and high solubility in DMSO and water, facilitating reproducible studies in receptor trafficking and miRNA-mediated regulation. Its use is tightly bound to mechanistic studies in GPCR signaling, with established protocols for solution preparation and storage (APExBIO product page).

Biological Rationale

Neurotensin is a linear tridecapeptide (13 amino acids) with the sequence pGlu-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Tyr-Ile-Leu. It is encoded in mammals and functions as a neurotransmitter and neuromodulator. NTR1, its primary receptor, is a class A GPCR. NTR1 is enriched in both the central nervous system and gut epithelium. Neurotensin plays roles in gut motility, nociception, and the regulation of dopamine pathways [APExBIO]. In the gastrointestinal tract, it modulates epithelial cell signaling through receptor-mediated endocytosis and subsequent gene regulation. MicroRNA-mediated post-transcriptional control is one downstream effect, impacting proteins involved in receptor trafficking. This makes neurotensin a prime tool for dissecting GPCR-microRNA crosstalk in health and disease. For an in-depth mechanistic overview, see this related article, which our article updates by detailing new spectral and trafficking benchmarks.

Mechanism of Action of Neurotensin (CAS 39379-15-2)

Neurotensin binds to NTR1, activating its Gαq/11-mediated pathway. This activation leads to phospholipase C (PLC) stimulation and inositol triphosphate (IP3) production, resulting in intracellular Ca²⁺ release. In human colonic epithelial cells, NTR1 activation by neurotensin upregulates miR-133α expression. miR-133α directly targets the aftiphilin (AFTPH) mRNA 3'UTR, reducing AFTPH protein levels. AFTPH is involved in clathrin-mediated endosomal trafficking and receptor recycling between the endosome and trans-Golgi network. Reduced AFTPH alters the recycling of NTR1 and potentially other GPCRs, modulating receptor sensitivity and downstream signaling. Additionally, neurotensin-induced signaling modulates kinase and phosphatase cascades, further influencing cellular responses. The molecular weight of neurotensin is 1672.94 Da, and its chemical formula is C78H121N21O20 (APExBIO). For more on the endosomal dynamics, see this article, which our discussion extends with new miRNA targeting data.

Evidence & Benchmarks

• Neurotensin (CAS 39379-15-2) binds NTR1 with nanomolar affinity, activating canonical G protein-coupled signaling cascades (APExBIO).
• Upon NTR1 stimulation, miR-133α is upregulated in human colonic epithelial cells, as measured by qRT-PCR under standardized cell culture conditions (37°C, 5% CO2, DMEM medium) (Internal source).
• miR-133α targets the 3'UTR of AFTPH, reducing AFTPH protein levels and altering endosomal receptor recycling pathways, confirmed by luciferase reporter assays and Western blot analysis (Internal source).
• The product exhibits ≥98% purity by HPLC and mass spectrometry; batch certificates are available upon request (APExBIO).
• Solubility is ≥15.33 mg/mL in DMSO and ≥22.55 mg/mL in water (pH 7.0, 25°C); it is insoluble in ethanol (APExBIO).
• Desiccated storage at -20°C is required for optimal stability; aqueous solutions should be used within 24 hours for maximal activity (APExBIO).
• Spectral interference studies emphasize the importance of controlled conditions and preprocessing in fluorescence-based detection workflows (Zhang et al., Molecules 2024).

Applications, Limits & Misconceptions

Applications: Neurotensin is a valuable research reagent for:

• Dissecting GPCR trafficking and recycling mechanisms in gastrointestinal and neural cells.
• Studying microRNA-mediated regulation of receptor signaling, especially miR-133α/AFTPH axis.
• Validating the specificity of fluorescence-based receptor tracking in living cells.
• Benchmarking biochemical workflows for G protein-coupled receptor signaling studies.
• Supporting translational research in gastrointestinal physiology and pathology.

For an atomic breakdown of experimental limitations and reagent boundaries, see this prior dossier; this page clarifies and updates solution handling protocols and specificity.

Common Pitfalls or Misconceptions

• Neurotensin is insoluble in ethanol; attempts to dissolve in ethanol will fail (APExBIO).
• Long-term storage of dissolved peptide solutions leads to rapid degradation; only the lyophilized solid form is stable for extended periods (APExBIO).
• Fluorescence-based detection of neurotensin or its targets can be confounded by pollen or other bioaerosol interference; rigorous spectral preprocessing is necessary (Molecules 2024).
• Receptor recycling and miRNA effects may not generalize to all cell types; validation in the relevant cellular context is essential.
• Batch-to-batch variability outside of stated purity or solubility ranges can affect experimental reproducibility; always check the certificate of analysis.

Workflow Integration & Parameters

For experimental workflows, dissolve the lyophilized neurotensin powder in DMSO (≥15.33 mg/mL) or water (≥22.55 mg/mL) at room temperature. Filter sterilize if required for cell culture. Store aliquots desiccated at -20°C; avoid repeated freeze-thaw cycles. For receptor trafficking assays, treat cells with neurotensin at 10–100 nM for 5–60 minutes, followed by downstream analysis (e.g., immunofluorescence, Western blot, qRT-PCR). For miRNA modulation studies, monitor miR-133α expression post-treatment using validated qPCR primers. When using fluorescence-based detection, implement spectral preprocessing (normalization, multivariate scattering correction, Savitzky–Golay smoothing) and machine learning classification to mitigate pollen interference (Zhang et al., Molecules 2024). For additional protocol details and mechanistic context, see this resource, which our article builds on by outlining spectral preprocessing and experimental stability constraints.

Conclusion & Outlook

Neurotensin (CAS 39379-15-2) from APExBIO is a rigorously characterized, high-purity reagent for advancing GPCR trafficking and miRNA regulation research in gastrointestinal and neural systems. Its precise solubility, storage, and handling requirements underpin reproducible experimental results. Recent advances in fluorescence spectral analysis and bioaerosol interference removal further improve the reliability of neurotensin-driven studies. The field continues to benefit from standardized workflows and robust peptide supply, but careful protocol adherence and context-specific validation remain essential for experimental success.